企業プロフィール

MEI Pharma 株価・ニュース・カタリスト

ティッカー:: MEIP
取引所:: NASDAQ
セクター:: Biopharma
所在地:: United States

株価変動の要因

Current closing-price context is not available for MEIP.

企業概要

事業概要

MEI Pharma was an oncology company focused on targeted cancer therapies before its restructuring and public-market decline. Its story centered on a concentrated development portfolio.

所在地とセクター分類

Headquartered in the United States and listed on NASDAQ before restructuring, MEI sat in specialty oncology biotechnology.

ビジネスモデルの特徴

The company depended on clinical data, portfolio management, and strategic capital decisions.

バイオ業界での位置付け

MEI belongs to the historical oncology-biotech category rather than the current live public-company set.

今後のカタリスト

MEI Pharma’s catalysts are strategic and portfolio-related, with any remaining oncology or capital update doing the work. The company is no longer a clear live-development story.